cAMP enhances BMP2-signaling through PKA and MKP1-dependent mechanisms

被引：32

作者：

Ghayor, Chafik ^{[1
]}

Ehrbar, Martin ^{[1
]}

Miguel, Blanca San ^{[1
]}

Graetz, Klaus W. ^{[1
]}

Weber, Franz E. ^{[1
]}

机构：

[1] Univ Zurich Hosp, Dept Craniomaxillofacial Surg, Zurich, Switzerland

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2009年 / 381卷 / 02期

关键词：

BMP; cAMP; Osteoblast; Bone regeneration; MKP1; ACTIVATED PROTEIN-KINASE; BONE MORPHOGENETIC PROTEINS; DIFFERENTIATION; CELLS; PATHWAY; BMP-2; EXPRESSION; P38;

D O I：

10.1016/j.bbrc.2009.02.032

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Recent studies suggest that the elevation of intracellular cyclic adenosine monophosphate (cAMP) and the activation of the protein kinase A regulate BMP-induced osteogenesis. However the precise mechanisms underlying the enhancing effect of cAMP oil BMP2 signaling were not completely revealed. in this study we investigated the effect of elevated cAMP level and PKA activation oil the BMP2-induced osteoblastic differentiation in pluripotent C2C12 cells. Alkaline phosphatase activity and its mRNA were consistently induced by BMP2 treatment. The pretreatment of C2C12 cells with Forskolin, a cAMP generating agent, dbcAMP, an analogue of cAMP, or IBMX(3-isobutyl 1-methyl xanthine), and a nonspecific inhibitor of phosphodiesterases elicited further activation of alkaline phosphatase. Furthermore, elevated intracellular cAMP level increased BMP2-induced MKP1. On the other hand, BMP2-induced Erk phosphorylation (p44/p42) and cell proliferation were suppressed in the presence of cAMP Thus cAMP might enhance., BMP2-induced osteoblastic differentiation by a MKM1-Erk-dependent mechanism. (C) 2009 Elsevier Inc. All rights reserved.

引用

页码：247 / 252

页数：6

共 30 条

[1]

BRONDELLO JM, 1995, ONCOGENE, V10, P1895

[2] Bone morphogenetic proteins, their antagonists, and the skeleton [J].

Canalis, E ;

Economides, AN ;

Gazzerro, E .

ENDOCRINE REVIEWS, 2003, 24 (02) :218-235

[3] Smad-dependent and Smad-independent pathways in TGF-β family signalling [J].

Derynck, R ;

Zhang, YE .

NATURE, 2003, 425 (6958) :577-584

[4] Diverse physiological functions for dual-specificity MAP kinase phosphatases [J].

Dickinson, Robin J. ;

Keyse, Stephen M. .

JOURNAL OF CELL SCIENCE, 2006, 119 (22) :4607-4615

[5] Anabolic agents and the bone morphogenetic protein pathway [J].

Garrett, I. R. .

CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOL 78, 2007, 78 :127-171

[6] Statins and bone formation [J].

Garrett, IR ;

Gutierrez, G ;

Mundy, GR .

CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (08) :715-736

[7] DIFFERENTIATION OF MUSCLE, FAT, CARTILAGE, AND BONE FROM PROGENITOR CELLS PRESENT IN A BONE-DERIVED CLONAL CELL-POPULATION - EFFECT OF DEXAMETHASONE [J].

GRIGORIADIS, AE ;

HEERSCHE, JNM ;

AUBIN, JE .

JOURNAL OF CELL BIOLOGY, 1988, 106 (06) :2139-2151

[8] Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation [J].

Guicheux, J ;

Lemonnier, J ;

Ghayor, C ;

Suzuki, A ;

Palmer, G ;

Caverzasio, J .

JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (11) :2060-2068

[9] Protein kinase a is a negative regulator of renal branching morphogenesis and modulates inhibitory and stimulatory bone morphogenetic proteins [J].

Gupta, IR ;

Piscione, TD ;

Grisaru, S ;

Phan, T ;

Macias-Silva, M ;

Zhou, XP ;

Whiteside, C ;

Wrana, JL ;

Rosenblum, ND .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (37) :26305-26314

[10]

Isogai Y, 1996, J BONE MINER RES, V11, P1384

← 1 2 3 →